Skip to content

ASBP

Aspire Biopharma Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.41
−4.21%
Ask drillr

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$1.00
EPS estimate
—
Revenue actual
$63.1K
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
—
EPS misses (12Q)
—
EPS in line (12Q)
—
Avg surprise (4Q)
—
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026—-$1.00—$63.1K
May 15, 2026—-$21—$28.4K
Mar 30, 2026—-$16—$4.3K
Nov 14, 2025—-$1.60—$1.9K
Aug 13, 2025—-$0.04——
May 14, 2025—-$0.42——
Nov 14, 2024—-$0.02——
Aug 16, 2024—-$0.02——
Jun 5, 2024—-$0.07——
Mar 11, 2024—-$0.00——
May 11, 2023—$0.02——
Mar 21, 2023—$0.02——

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026